Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Cash from Operations (2022 - 2025)

Corvus Pharmaceuticals has reported Cash from Operations over the past 4 years, most recently at 9191000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 9191000.0 for Q4 2025, down 8.58% from a year ago — trailing twelve months through Dec 2025 was 32797000.0 (down 29.0% YoY), and the annual figure for FY2025 was 32797000.0, down 29.0%.
  • Cash from Operations for Q4 2025 was 9191000.0 at Corvus Pharmaceuticals, up from 9566000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for CRVS hit a ceiling of 5157000.0 in Q1 2024 and a floor of 9566000.0 in Q3 2025.
  • Median Cash from Operations over the past 4 years was 6372500.0 (2022), compared with a mean of 6823687.5.
  • Peak annual rise in Cash from Operations hit 36.42% in 2024, while the deepest fall reached 63.83% in 2024.
  • Corvus Pharmaceuticals' Cash from Operations stood at 7547000.0 in 2022, then soared by 31.54% to 5167000.0 in 2023, then tumbled by 63.83% to 8465000.0 in 2024, then decreased by 8.58% to 9191000.0 in 2025.
  • The last three reported values for Cash from Operations were 9191000.0 (Q4 2025), 9566000.0 (Q3 2025), and 5777000.0 (Q2 2025) per Business Quant data.